STAT+: EU orders Illumina to divest cancer diagnostics firm Grail
LONDON — European regulators on Thursday detailed their demands that Illumina divest the cancer diagnostics…
Category: Life Sciences
Opinion: How kangaroo mother care can help millions of babies each year
More than one in 10 infants worldwide are born preterm, many with complications: Nearly 1…
.jpg)
Treating Rural America: The new country doctors
Family medicine physician Olusunmisola Oyesiku always thought she would practice in a big city, but…
STAT+: Peter Marks on creating Operation Warp Speed, but for rare diseases
Peter Marks wants drug developers to ask more stupid questions. It’s part of the top…
STAT+: Life sciences deals on track to hit lowest point since 2017
It’s no secret that biotech industry funding has fallen from its Covid highs. But with…
FDA Issues Warning Over Misuse of Ketamine Therapy – The New York Times
FDA Issues Warning Over Misuse of Ketamine Therapy The New York Times Read Original Article: FDA…
Health Disclaimer – The Vashon Loop – vashonloop
Health Disclaimer – The Vashon Loop vashonloop Read Original Article: Health Disclaimer – The Vashon Loop…
Antibiotics “Like Gold” for Some Patients: Personal Beliefs and … – IDSA
Antibiotics “Like Gold” for Some Patients: Personal Beliefs and … IDSA Read Original Article: Antibiotics “Like…
Take 5 With Dyer Brown Architects’ Maggie Mitchell – HCD Magazine – Healthcare Design
Take 5 With Dyer Brown Architects’ Maggie Mitchell – HCD Magazine Healthcare Design Read Original Article:…
STAT+: Key takeaways from AdvaMed, the world’s largest medical device conference
ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week…
STAT+: CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer
A company that Pfizer blamed for problems with a clinical trial testing a Lyme vaccine…
STAT+: Humana CEO Bruce Broussard to step down next year
Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading…
STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs
Anticipation may be high that Medicare can wring lower prices out of drugmakers, but a…
STAT+: European regulators consider appeal over Amylyx ALS drug
LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially…
In major test for eGenesis, gene-edited pig kidneys kept monkeys alive for more than two years
Scientists at a Massachusetts-based biotechnology company and their academic research partners reported Wednesday that an…
With Ozempic, Wall Street moves on from a whole other class of medicines
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
Major biomedical research funder Wellcome Trust names Røttingen as its new CEO
LONDON — The Wellcome Trust — the world’s second largest private funder of biomedical research…
Chronic kidney disease raises risk of sudden cardiac arrest among Hispanics and Latinos
Chronic kidney disease was the strongest risk factor for sudden cardiac arrest among Hispanic and…
The ‘abortion queen’ wants patients to have ‘skin in the game.’ Is that restricting access?
BRISTOL, Va. — Stephanie Rosenwinge was excited to work for the queen of abortion. She’d…
Opinion: The Wegovy shortage is part of a much bigger problem with weight loss drugs
After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema…
Opinion: How good are AI health technologies? We have no idea
AI has the ability to revolutionize human health. It is used to detect potentially cancerous lesions in…
‘What I’m most proud of’: Nick Jonas talks about managing diabetes, his career, and building community
LAS VEGAS – Nick Jonas is a global superstar behind electrifying earworms like “Jealous,” “Chains,”…
STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts
Gina Calvanese got laid off from Jounce Therapeutics, a struggling Cambridge biotech, in April but…
Survey: Most Cancer Patients Use Complementary or Alternative … – Renal and Urology News
Survey: Most Cancer Patients Use Complementary or Alternative … Renal and Urology News Read Original Article:…
WHO’s Evidence Anyway? The Extra Careful Mainstreaming Of … – Worldcrunch
WHO’s Evidence Anyway? The Extra Careful Mainstreaming Of … Worldcrunch Read Original Article: WHO’s Evidence Anyway?…
An EpiPen Alternative Could Make Treating Anaphylaxis Easier … – Verywell Health
An EpiPen Alternative Could Make Treating Anaphylaxis Easier … Verywell Health Read Original Article: An EpiPen…
STAT+: Bernie Sanders bashes nonprofit hospitals over their tax breaks
WASHINGTON — Hospitals get tax breaks that are worth far more than the value of…
Robert F. Kennedy is pitching centrism on health care, even on abortion
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
What’s next in the Kaiser Permanente strike
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Dana-Farber CEO on Mass General split: Boston needed a dedicated cancer hospital
One of the first items on Laurie Glimcher’s agenda after becoming CEO of the renowned…
STAT+: Sana to lay off nearly a third of staff, de-prioritize a key program
Sana Biotechnology, a startup that just a couple years ago raised over $1 billion off…
STAT+: A fraught question for the children of Alzheimer’s: Is it coming for us?
My sister has a fantasy about our old age: She imagines that the seven siblings…
STAT+: How doctors and nurses shape Google’s AI, DEA extends telehealth flexibilities
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech…
To protect chickens from bird flu, researchers try to CRISPR in immunity
LONDON — In this case, it was neither the chicken nor the egg that came…
Want a biotech buyout? Target cancer
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024
Hello, everyone, and nice to see you again. We have returned from an extended weekend…
STAT+: Akero’s treatment for NASH falls short in cirrhosis study
Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for…
The ‘model-eat-model world’ of clinical AI: How predictive power becomes a pitfall
A growing number of AI tools are being used to predict everything from sepsis to…
Opinion: Connecticut’s comptroller explains his thinking about GLP-1s for state employees
This article is part of a partnership between First Opinion and Tradeoffs, a podcast exploring our…
With a rare immunodeficiency disease, a performer and patient advocate learned lessons the hard way
When asked where he’s from, Casey Warford often waffles. He was born in San Antonio,…
Stroke deaths, despite advances in prevention, are set to near 10 million globally by 2050
The number of stroke deaths worldwide is set to climb 50% to nearly 10 million…
STAT+: Bristol ‘take-under’ of Mirati is not so great for biotech, but company’s new cancer target has potential
Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics: A take-under deal feels meh…
STAT+: FDA rejects Alnylam’s heart disease treatment over insufficient data
The Food and Drug Administration rejected an Alnylam Pharmaceuticals’ therapy for an increasingly prevalent heart…
STAT+: Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies
Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect…
STAT+: A Q&A with the global head of Boehringer Ingelheim’s innovation unit
LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined…
STAT+: Venture capital firm General Catalyst wants to buy a health system
Venture firms, convinced they’re jumpstarting the world’s most helpful tech products, have struggled mightily to…
Diverse diets for stronger bones: Study reveals how alternative … – News-Medical.Net
Diverse diets for stronger bones: Study reveals how alternative … News-Medical.Net Read Original Article: Diverse diets…
Public Use of Complementary Medicine for Children in Saudi Arabia … – Cureus
Public Use of Complementary Medicine for Children in Saudi Arabia … Cureus Read Original Article: Public…
Revitalize Health: A Look at PEMF, Rife, and Other Alternative … – Intelligent Living
Revitalize Health: A Look at PEMF, Rife, and Other Alternative … Intelligent Living Read Original Article:…